Catalyst Wire Dossier Catalyst Wire Dossier

Mite allergen immunotherapy (investigational)

· Inmunotek S.L.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Mite allergen immunotherapy (investigational), covering 2025-05-13 to 2025-05-13. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety Evaluation for the Treatment of Allergy Against Mites [Phase 3]

See pricing